APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dog Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Dog Vaccines Industry Growth and Trends Forecast to 2032

Report ID 173985520122 December 2025105 pages

Choose your research edition.

Industry ResearchDog Vaccines Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Dog Vaccines Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Dog Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dog Vaccines Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dog Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Dog Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Dog Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Dog Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dog Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Dog Vaccines include Zoetis (Pfizer), Merck Animal Health, Eli Lilly, Bayer Healthcare, Virbac, Vetoquinol S.A, Merial (Sanofi), Heska Co. and Ceva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Dog Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dog Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dog Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dog Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dog Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dog Vaccines Market by Company

Zoetis (Pfizer)

Merck Animal Health

Eli Lilly

Bayer Healthcare

Virbac

Vetoquinol S.A

Merial (Sanofi)

Heska Co.

Ceva

Boehringer Ingelheim

Dog Vaccines Segment by Type

Recombinant Vaccines

Subunit Vaccines

Inactivated Vaccines

Toxoid Vaccines

Attenuated Live Vaccines

Conjugate Vaccines

DNA Vaccines

Dog Vaccines Segment by Application

Below 6 Months

Above Months

Dog Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dog Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dog Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dog Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dog Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dog Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Recombinant Vaccines Table 2. Major Company of Subunit Vaccines Table 3. Major Company of Inactivated Vaccines Table 4. Major Company of Toxoid Vaccines Table 5. Major Company of Attenuated Live Vaccines Table 6. Major Company of Conjugate Vaccines Table 7. Major Company of DNA Vaccines Table 8. Global Dog Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Dog Vaccines Sales by Type (2021-2026) & (k units) Table 10. Global Dog Vaccines Sales Market Share in Volume by Type (2021-2026) Table 11. Global Dog Vaccines Sales by Type (2021-2026) & (US$ Million) Table 12. Global Dog Vaccines Sales Market Share in Value by Type (2021-2026) Table 13. Global Dog Vaccines Price by Type (2021-2026) & (US$/unit) Table 14. Global Dog Vaccines Sales by Type (2027-2032) & (k units) Table 15. Global Dog Vaccines Sales Market Share in Volume by Type (2027-2032) Table 16. Global Dog Vaccines Sales by Type (2027-2032) & (US$ Million) Table 17. Global Dog Vaccines Sales Market Share in Value by Type (2027-2032) Table 18. Global Dog Vaccines Price by Type (2027-2032) & (US$/unit) Table 19. North America Dog Vaccines Sales by Type (2021-2026) & (k units) Table 20. North America Dog Vaccines Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Dog Vaccines Sales by Type (2021-2026) & (k units) Table 22. Europe Dog Vaccines Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Dog Vaccines Sales by Type (2021-2026) & (k units) Table 24. Asia-Pacific Dog Vaccines Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Dog Vaccines Sales by Type (2021-2026) & (k units) Table 26. Latin America Dog Vaccines Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Dog Vaccines Sales by Type (2021-2026) & (k units) Table 28. Middle East and Africa Dog Vaccines Sales by Type (2021-2026) & (US$ Million) Table 29. Dog Vaccines Industry Trends Table 30. Dog Vaccines Industry Drivers Table 31. Dog Vaccines Industry Opportunities and Challenges Table 32. Dog Vaccines Industry Restraints Table 33. Global Dog Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Dog Vaccines Revenue Market Share by Company (2021-2026) Table 35. Global Dog Vaccines Sales by Company (2021-2026) & (k units) Table 36. Global Dog Vaccines Sales Share by Company (2021-2026) Table 37. Global Dog Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 38. Global Dog Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Dog Vaccines Major Company Production Sites and Headquarters Table 40. Global Dog Vaccines Company, Product Type & Application Table 41. Global Dog Vaccines Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Dog Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Dog Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Dog Vaccines Sales by Region (2021-2026) & (k units) Table 46. Global Dog Vaccines Sales Market Share in Volume by Region (2021-2026) Table 47. Global Dog Vaccines Sales by Region (2021-2026) & (US$ Million) Table 48. Global Dog Vaccines Sales Market Share in Value by Region (2021-2026) Table 49. Global Dog Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 50. Global Dog Vaccines Sales by Region (2027-2032) & (k units) Table 51. Global Dog Vaccines Sales Market Share in Volume by Region (2027-2032) Table 52. Global Dog Vaccines Sales by Region (2027-2032) & (US$ Million) Table 53. Global Dog Vaccines Sales Market Share in Value by Region (2027-2032) Table 54. Global Dog Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 55. Global Dog Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Dog Vaccines Sales by Application (2021-2026) & (k units) Table 57. Global Dog Vaccines Sales Market Share in Volume by Application (2021-2026) Table 58. Global Dog Vaccines Sales by Application (2021-2026) & (US$ Million) Table 59. Global Dog Vaccines Sales Market Share in Value by Application (2021-2026) Table 60. Global Dog Vaccines Price by Application (2021-2026) & (US$/unit) Table 61. Global Dog Vaccines Sales by Application (2027-2032) & (k units) Table 62. Global Dog Vaccines Sales Market Share in Volume by Application (2027-2032) Table 63. Global Dog Vaccines Sales by Application (2027-2032) & (US$ Million) Table 64. Global Dog Vaccines Sales Market Share in Value by Application (2027-2032) Table 65. Global Dog Vaccines Price by Application (2027-2032) & (US$/unit) Table 66. North America Dog Vaccines Sales by Application (2021-2026) & (k units) Table 67. North America Dog Vaccines Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Dog Vaccines Sales by Application (2021-2026) & (k units) Table 69. Europe Dog Vaccines Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Dog Vaccines Sales by Application (2021-2026) & (k units) Table 71. Asia-Pacific Dog Vaccines Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Dog Vaccines Sales by Application (2021-2026) & (k units) Table 73. Latin America Dog Vaccines Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Dog Vaccines Sales by Application (2021-2026) & (k units) Table 75. Middle East and Africa Dog Vaccines Sales by Application (2021-2026) & (US$ Million) Table 76. Zoetis (Pfizer) Company Information Table 77. Zoetis (Pfizer) Business Overview Table 78. Zoetis (Pfizer) Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Zoetis (Pfizer) Dog Vaccines Product Portfolio Table 80. Zoetis (Pfizer) Recent Development Table 81. Merck Animal Health Company Information Table 82. Merck Animal Health Business Overview Table 83. Merck Animal Health Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck Animal Health Dog Vaccines Product Portfolio Table 85. Merck Animal Health Recent Development Table 86. Eli Lilly Company Information Table 87. Eli Lilly Business Overview Table 88. Eli Lilly Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Eli Lilly Dog Vaccines Product Portfolio Table 90. Eli Lilly Recent Development Table 91. Bayer Healthcare Company Information Table 92. Bayer Healthcare Business Overview Table 93. Bayer Healthcare Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Bayer Healthcare Dog Vaccines Product Portfolio Table 95. Bayer Healthcare Recent Development Table 96. Virbac Company Information Table 97. Virbac Business Overview Table 98. Virbac Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Virbac Dog Vaccines Product Portfolio Table 100. Virbac Recent Development Table 101. Vetoquinol S.A Company Information Table 102. Vetoquinol S.A Business Overview Table 103. Vetoquinol S.A Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Vetoquinol S.A Dog Vaccines Product Portfolio Table 105. Vetoquinol S.A Recent Development Table 106. Merial (Sanofi) Company Information Table 107. Merial (Sanofi) Business Overview Table 108. Merial (Sanofi) Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Merial (Sanofi) Dog Vaccines Product Portfolio Table 110. Merial (Sanofi) Recent Development Table 111. Heska Co. Company Information Table 112. Heska Co. Business Overview Table 113. Heska Co. Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Heska Co. Dog Vaccines Product Portfolio Table 115. Heska Co. Recent Development Table 116. Ceva Company Information Table 117. Ceva Business Overview Table 118. Ceva Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Ceva Dog Vaccines Product Portfolio Table 120. Ceva Recent Development Table 121. Boehringer Ingelheim Company Information Table 122. Boehringer Ingelheim Business Overview Table 123. Boehringer Ingelheim Dog Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. Boehringer Ingelheim Dog Vaccines Product Portfolio Table 125. Boehringer Ingelheim Recent Development Table 126. North America Dog Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. North America Dog Vaccines Sales by Country (2021-2026) & (k units) Table 128. North America Dog Vaccines Sales Market Share by Country (2021-2026) Table 129. North America Dog Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 130. North America Dog Vaccines Sales Market Share Forecast by Country (2027-2032) Table 131. North America Dog Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Dog Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Dog Vaccines Market Share by Country (2021-2026) Table 134. North America Dog Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Dog Vaccines Market Share Forecast by Country (2027-2032) Table 136. Europe Dog Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Europe Dog Vaccines Sales by Country (2021-2026) & (k units) Table 138. Europe Dog Vaccines Sales Market Share by Country (2021-2026) Table 139. Europe Dog Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 140. Europe Dog Vaccines Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Dog Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Dog Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Dog Vaccines Market Share by Country (2021-2026) Table 144. Europe Dog Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Dog Vaccines Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Dog Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Dog Vaccines Sales by Country (2021-2026) & (k units) Table 148. Asia-Pacific Dog Vaccines Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Dog Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 150. Asia-Pacific Dog Vaccines Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Dog Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Dog Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Dog Vaccines Market Share by Country (2021-2026) Table 154. Asia-Pacific Dog Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Dog Vaccines Market Share Forecast by Country (2027-2032) Table 156. Latin America Dog Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Latin America Dog Vaccines Sales by Country (2021-2026) & (k units) Table 158. Latin America Dog Vaccines Sales Market Share by Country (2021-2026) Table 159. Latin America Dog Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 160. Latin America Dog Vaccines Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Dog Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Dog Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Dog Vaccines Market Share by Country (2021-2026) Table 164. Latin America Dog Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Dog Vaccines Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Dog Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Dog Vaccines Sales by Country (2021-2026) & (k units) Table 168. Middle East and Africa Dog Vaccines Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Dog Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 170. Middle East and Africa Dog Vaccines Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Dog Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Dog Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Dog Vaccines Market Share by Country (2021-2026) Table 174. Middle East and Africa Dog Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Dog Vaccines Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Dog Vaccines Distributors List Table 179. Dog Vaccines Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Dog Vaccines Image Figure 2. Global Dog Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dog Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Dog Vaccines Sales (2021-2032) & (k units) Figure 5. Recombinant Vaccines Image Figure 6. Global Recombinant Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 7. Subunit Vaccines Image Figure 8. Global Subunit Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 9. Inactivated Vaccines Image Figure 10. Global Inactivated Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 11. Toxoid Vaccines Image Figure 12. Global Toxoid Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 13. Attenuated Live Vaccines Image Figure 14. Global Attenuated Live Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 15. Conjugate Vaccines Image Figure 16. Global Conjugate Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 17. DNA Vaccines Image Figure 18. Global DNA Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 19. Global Dog Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Dog Vaccines Market Share by Type 2025 VS 2032 Figure 21. North America Dog Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. North America Dog Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Europe Dog Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Europe Dog Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Dog Vaccines Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Dog Vaccines Sales Market Share in Value by Type in 2025 Figure 27. Latin America Dog Vaccines Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Dog Vaccines Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Dog Vaccines Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Dog Vaccines Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Dog Vaccines Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Below 6 Months Image Figure 34. Global Below 6 Months Sales YoY Growth (2021-2032) & (k units) Figure 35. Above Months Image Figure 36. Global Above Months Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Dog Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Dog Vaccines Market Share by Application 2025 VS 2032 Figure 39. North America Dog Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. North America Dog Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Europe Dog Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Europe Dog Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Dog Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Dog Vaccines Sales Market Share in Value by Application in 2025 Figure 45. Latin America Dog Vaccines Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Dog Vaccines Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Dog Vaccines Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Dog Vaccines Sales Market Share in Value by Application in 2025 Figure 49. North America Dog Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Dog Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Dog Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Dog Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Dog Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Dog Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Dog Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Dog Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Dog Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Dog Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Dog Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Dog Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Dog Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Dog Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Dog Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Dog Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Dog Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Dog Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Dog Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Dog Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Dog Vaccines Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Dog Vaccines Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Vaccines
  • Subunit Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • DNA Vaccines
Applications
  • Below 6 Months
  • Above Months
Companies covered
  • Zoetis (Pfizer)
  • Merck Animal Health
  • Eli Lilly
  • Bayer Healthcare
  • Virbac
  • Vetoquinol S.A
  • Merial (Sanofi)
  • Heska Co.
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dog Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dog Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dog Vaccines Market by Type
  6. 1.3.1 Recombinant Vaccines
  7. 1.3.2 Subunit Vaccines
  8. 1.3.3 Inactivated Vaccines
  9. 1.3.4 Toxoid Vaccines
  10. 1.3.5 Attenuated Live Vaccines
  11. 1.3.6 Conjugate Vaccines
  12. 1.3.7 DNA Vaccines
  13. 1.4 Global Dog Vaccines Market Size by Type
  14. 1.4.1 Global Dog Vaccines Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Dog Vaccines Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Dog Vaccines Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Dog Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Dog Vaccines Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Dog Vaccines Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Dog Vaccines Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Dog Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dog Vaccines Industry Trends
  2. 2.2 Dog Vaccines Industry Drivers
  3. 2.3 Dog Vaccines Industry Opportunities and Challenges
  4. 2.4 Dog Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dog Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Dog Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Dog Vaccines Price (2021-2026)
  4. 3.4 Global Dog Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dog Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Dog Vaccines Company, Product Type & Application
  7. 3.7 Global Dog Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dog Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dog Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dog Vaccines Tier 1, Tier 2, and Tier 3
4 Dog Vaccines Regional Status and Outlook
  1. 4.1 Global Dog Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dog Vaccines Historic Market Size by Region
  3. 4.2.1 Global Dog Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dog Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dog Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dog Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Dog Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dog Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dog Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dog Vaccines by Application
  1. 5.1 Dog Vaccines Market by Application
  2. 5.1.1 Below 6 Months
  3. 5.1.2 Above Months
  4. 5.2 Global Dog Vaccines Market Size by Application
  5. 5.2.1 Global Dog Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Dog Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Dog Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Dog Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Dog Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Dog Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Dog Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Dog Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis (Pfizer)
  2. 6.1.1 Zoetis (Pfizer) Company Information
  3. 6.1.2 Zoetis (Pfizer) Business Overview
  4. 6.1.3 Zoetis (Pfizer) Dog Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis (Pfizer) Dog Vaccines Product Portfolio
  6. 6.1.5 Zoetis (Pfizer) Recent Developments
  7. 6.2 Merck Animal Health
  8. 6.2.1 Merck Animal Health Company Information
  9. 6.2.2 Merck Animal Health Business Overview
  10. 6.2.3 Merck Animal Health Dog Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck Animal Health Dog Vaccines Product Portfolio
  12. 6.2.5 Merck Animal Health Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Dog Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Eli Lilly Dog Vaccines Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 Bayer Healthcare
  20. 6.4.1 Bayer Healthcare Company Information
  21. 6.4.2 Bayer Healthcare Business Overview
  22. 6.4.3 Bayer Healthcare Dog Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Healthcare Dog Vaccines Product Portfolio
  24. 6.4.5 Bayer Healthcare Recent Developments
  25. 6.5 Virbac
  26. 6.5.1 Virbac Company Information
  27. 6.5.2 Virbac Business Overview
  28. 6.5.3 Virbac Dog Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Virbac Dog Vaccines Product Portfolio
  30. 6.5.5 Virbac Recent Developments
  31. 6.6 Vetoquinol S.A
  32. 6.6.1 Vetoquinol S.A Company Information
  33. 6.6.2 Vetoquinol S.A Business Overview
  34. 6.6.3 Vetoquinol S.A Dog Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Vetoquinol S.A Dog Vaccines Product Portfolio
  36. 6.6.5 Vetoquinol S.A Recent Developments
  37. 6.7 Merial (Sanofi)
  38. 6.7.1 Merial (Sanofi) Company Information
  39. 6.7.2 Merial (Sanofi) Business Overview
  40. 6.7.3 Merial (Sanofi) Dog Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Merial (Sanofi) Dog Vaccines Product Portfolio
  42. 6.7.5 Merial (Sanofi) Recent Developments
  43. 6.8 Heska Co.
  44. 6.8.1 Heska Co. Company Information
  45. 6.8.2 Heska Co. Business Overview
  46. 6.8.3 Heska Co. Dog Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Heska Co. Dog Vaccines Product Portfolio
  48. 6.8.5 Heska Co. Recent Developments
  49. 6.9 Ceva
  50. 6.9.1 Ceva Company Information
  51. 6.9.2 Ceva Business Overview
  52. 6.9.3 Ceva Dog Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ceva Dog Vaccines Product Portfolio
  54. 6.9.5 Ceva Recent Developments
  55. 6.10 Boehringer Ingelheim
  56. 6.10.1 Boehringer Ingelheim Company Information
  57. 6.10.2 Boehringer Ingelheim Business Overview
  58. 6.10.3 Boehringer Ingelheim Dog Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Boehringer Ingelheim Dog Vaccines Product Portfolio
  60. 6.10.5 Boehringer Ingelheim Recent Developments
7 North America by Country
  1. 7.1 North America Dog Vaccines Sales by Country
  2. 7.1.1 North America Dog Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dog Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Dog Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dog Vaccines Market Size by Country
  6. 7.2.1 North America Dog Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dog Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Dog Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dog Vaccines Sales by Country
  2. 8.1.1 Europe Dog Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dog Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Dog Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dog Vaccines Market Size by Country
  6. 8.2.1 Europe Dog Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dog Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dog Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dog Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Dog Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dog Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dog Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dog Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Dog Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dog Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dog Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dog Vaccines Sales by Country
  2. 10.1.1 South America Dog Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dog Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Dog Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dog Vaccines Market Size by Country
  6. 10.2.1 South America Dog Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dog Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Dog Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dog Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Dog Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dog Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dog Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dog Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Dog Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dog Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dog Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dog Vaccines Value Chain Analysis
  2. 12.1.1 Dog Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dog Vaccines Production Mode & Process
  7. 12.2 Dog Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dog Vaccines Distributors
  10. 12.2.3 Dog Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst